Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacrifill for Dry Eye in Contact Lens Wearers
NCT07510620Phase 4Recruiting
- Sponsor
- Vision Innovation Partners
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Modality
- Hydrogel Systems, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lacrifill in dry eye syndrome (DED), sponsored by Vision Innovation Partners. Primary endpoints: Dry eye signs, Dry Eye Symptoms and 1 more. Started Dec 2025; status: recruiting.
02
Drugs
Lacrifill
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT07510620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07510620.